Weight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...

Pennsylvania is evolving, and our workforce development system needs to adapt to this change. For years, there have been flashing red lights on Pennsylvania’s demographic dashboard. Our ...

Biotech 4DMT lays off 25% of workforce while accelerating phase 3 eye gene therapy timeline By James Waldron Jul 3, 2025 4:52am 4D Molecular Therapeutics Cell & Gene Therapy layoffs wet AMD ...

It’s no secret that America’s shipbuilding workforce is in crisis. The nation is struggling to retain a sufficient workforce to meet existing requirements. It’s also no secret that China is outpacing ...

The case joins a list of high-profile celebrity trials, including those of O.J. Simpson, Michael Jackson, Harvey Weinstein and Alec Baldwin, that have captured public attention.

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.

HealthDay News — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study ...

Microsoft said it will cut less than 4% of its workforce, or roughly 9,000 jobs, as it aims to get rid of layers of management and utilize new technologies. The news comes as the company invests ...

Companies are helping employees work smarter by deploying cloud-based collaboration tools, AI-powered workforce management platforms and secure mobile networks. IT modernization is at the core of ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain ...

Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's multibillion-dollar heart drug. A new BMJ investigation reveals data ...